Drugs / low-dose
low-dose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04557267 | Sep 2020 → May 2021 | obesity disorder | Indonesia University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | low-dose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04557267 ↗ |
| Known as | Kacip Fatimah extract | “In Malaysia, this Kacip Fatimah extract has been used as a natural anti-obesity drug and dietary supplement for healthy weight loss and healthy body by the trade-name of...” NCT04557267 ↗ |
| Known as | Labeesity | “In Malaysia, this Kacip Fatimah extract has been used as a natural anti-obesity drug and dietary supplement for healthy weight loss and healthy body by the trade-name of...” NCT04557267 ↗ |